Literature DB >> 17319985

Laser inferior turbinectomy under local anaesthetic: a well tolerated out-patient procedure.

S Maskell1, N Eze, P Patel, A Hosni.   

Abstract

The suitability of performing laser inferior turbinectomy under local anaesthesia in an out-patient setting was assessed, regarding its effectiveness and patients' toleration of the procedure. Prospective data collection was undertaken from 129 patients undergoing laser inferior turbinectomy over four years. Patients were assessed, pre-operatively, operatively and at two weeks and three months post-operatively, for pain, complications and symptoms, using the sino-nasal assessment questionnaire. All patients had hypertrophied inferior turbinates. Ninety-eight patients complained of nasal obstruction and 67 had the procedure as part of treatment for snoring. One hundred and twenty-one of the patients had treatment to both inferior turbinates. There were no cases of intra-operative haemorrhage. The average pre-operative sino-nasal assessment questionnaire score was 18.22, which improved to 10.68 at the three month post-operative assessment (p<0.001). Five patients had significant intra-operative pain. This study shows that laser inferior turbinectomy under local anaesthesia is well tolerated and that good results can be achieved when performing the procedure in the out-patient department.

Entities:  

Mesh:

Year:  2007        PMID: 17319985     DOI: 10.1017/S0022215107005919

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  2 in total

1.  Diode laser turbinate reduction in the treatment of symptomatic inferior turbinate hypertrophy.

Authors:  Pradipta Kumar Parida; Gopalakrishnan Surianarayanan; Arun Alexander; Sunil Kumar Saxena; Krishnapriya Santhosh
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-02-19

2.  Diode Laser Reduction of Symptomatic Inferior Turbinate Hypertrophy.

Authors:  Nain Bahadur Mahato; Deepak Regmi; Meera Bista
Journal:  JNMA J Nepal Med Assoc       Date:  2018 Nov-Dec       Impact factor: 0.406

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.